Screener
Aldeyra Therapeutics ALDX Q3 2025 earnings
Reported November 5, 2025 · Before market open
EPS-$0.13Beat by $0.04
Revenue estimate$24.3M
EPS estimate-$0.17
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$2.5M
EPS estimate-$0.11
Versus estimates
Diluted EPS
FAQ
- When did Aldeyra Therapeutics report Q3 2025 earnings?
- Aldeyra Therapeutics (ALDX) reported Q3 2025 earnings on November 5, 2025 before market open.
- What were Aldeyra Therapeutics's Q3 2025 revenue and EPS?
- Aldeyra Therapeutics reported eps of $-0.13 for Q3 2025.
- Did Aldeyra Therapeutics beat estimates in Q3 2025?
- EPS beat the consensus estimate of $-0.17 by $0.04.
- How did Aldeyra Therapeutics's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 48.0% from $-0.25.
- Where can I find Aldeyra Therapeutics's Q3 2025 SEC filings?
- You can read the 10-Q periodic report (0001193125-25-266989) directly on SEC EDGAR. The filing index links above go to sec.gov.
